- Home
- RLMD vs DERM Comparison
RLMD vs DERM Comparison
Compare RLMD & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLMD
- DERM
- Stock Information
- Founded
- RLMD 2004
- DERM 2014
- Country
- RLMD United States
- DERM United States
- Employees
- RLMD N/A
- DERM N/A
- Industry
- RLMD Biotechnology: Pharmaceutical Preparations
- DERM Biotechnology: Pharmaceutical Preparations
- Sector
- RLMD Health Care
- DERM Health Care
- Exchange
- RLMD Nasdaq
- DERM Nasdaq
- Market Cap
- RLMD 110.6M
- DERM 124.4M
- IPO Year
- RLMD N/A
- DERM 2021
- Fundamental
- Price
- RLMD $3.16
- DERM $5.12
- Analyst Decision
- RLMD Hold
- DERM Strong Buy
- Analyst Count
- RLMD 2
- DERM 3
- Target Price
- RLMD $7.50
- DERM $9.50
- AVG Volume (30 Days)
- RLMD 110.4K
- DERM 159.2K
- Earning Date
- RLMD 11-07-2024
- DERM 11-12-2024
- Dividend Yield
- RLMD N/A
- DERM N/A
- EPS Growth
- RLMD N/A
- DERM N/A
- EPS
- RLMD N/A
- DERM 0.04
- Revenue
- RLMD N/A
- DERM $77,681,000.00
- Revenue This Year
- RLMD N/A
- DERM N/A
- Revenue Next Year
- RLMD N/A
- DERM $37.38
- P/E Ratio
- RLMD N/A
- DERM N/A
- Revenue Growth
- RLMD N/A
- DERM 26.38
- 52 Week Low
- RLMD $1.88
- DERM $2.85
- 52 Week High
- RLMD $7.22
- DERM $8.11
- Technical
- Relative Strength Index (RSI)
- RLMD 39.24
- DERM 40.53
- Support Level
- RLMD $3.06
- DERM $5.00
- Resistance Level
- RLMD $3.43
- DERM $5.82
- Average True Range (ATR)
- RLMD 0.20
- DERM 0.44
- MACD
- RLMD -0.04
- DERM -0.08
- Stochastic Oscillator
- RLMD 16.30
- DERM 8.78
About RLMD Relmada Therapeutics Inc.
Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its lead product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's portfolio includes eight branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the United States. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.